23983-43-9 (普拉雄酮庚酸酯,(3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-oxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopentaaphenanthren-3-yl Heptanoate)

普拉雄酮庚酸酯;去氢表雄酮庚酸酯;脱氢表雄酮庚酸酯;庚酸去氢表雄酮;去氢表雄酮庚酸酯（普拉雄酮庚酸酯）;

Dehydroepiandrosterone enanthate;3b-Hydroxyandrost-5-en-17-one heptanoate;(3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-oxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl heptanoate;DHEAenanthate;Ezetimibe;PRASTERONE ENANTHATE;3beta-Heptanoyloxy-5-androsten-17-one;Androst-5-en-17-one,3-[(1-oxoheptyl)oxy]-, (3b)-;Dehydroepiandrosterone oenanthate;Dhea oenanthate;Einecs 245-970-8;BCP10784;DS-13434;UNII-2W8I1S6T5L;SCHEMBL2453080;PRASTERONE ENANTATE [MART.];Prasterone enantate;[(3S, 8R, 9S, 10R, 13S, 14S)-10, 13-dimethyl-17-oxo-1, 2, 3, 4, 7, 8, 9, 11, 12, 14, 15, 16-dodecahydrocyclopenta[a]phenanthren-3-yl] heptanoate;NS00051444;Q27255695;23983-43-9;[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] heptanoate;PRASTERONE ENANTATE [WHO-DD];3.BETA.-HEPTANOYLOXY-5-ANDROSTEN-17-ONE;3beta-Hydroxyandrost-5-en-17-one heptanoate;DTXSID00946833;AKOS025310707;2W8I1S6T5L;Androst-5-en-17-one, 3-[(1-oxoheptyl)oxy]-, (3b)-;DHEA enanthate;

HHENOUDBWKNPAB-BNCSLUSBSA-N

1S/C26H40O3/c1-4-5-6-7-8-24(28)29-19-13-15-25(2)18(17-19)9-10-20-21-11-12-23(27)26(21,3)16-14-22(20)25/h9,19-22H,4-8,10-17H2,1-3H3/t19-,20-,21-,22-,25-,26-/m0/s1

O=C1CC[C@@H]2[C@]1(C)CC[C@@H]1[C@@]3(C)CC[C@@H](CC3=CC[C@H]12)OC(CCCCCC)=O

245-970-8